The interesting pharmacological properties together with a promising “drugability” designate this group of chemical molecules as a good starting point for further consideration in order to explore molecular mechanisms of the 5-HT6R–ligand interaction, and even to search of new drug candidates for the treatment of depression and obesity. The gene discussed is HTR6; the disease is major depressive disorder.